
P/E Ratio: Price to Earnings - Most used valuation metric
Analyzing Investment Quality
Processing 9 key metrics...
Loading shareholding data...
No insider trading data available
Standard pivot points - most widely used
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹5935.83 | +₹391.33 | +7.06% |
| R3 | ₹5785.33 | +₹240.83 | +4.34% |
| R2 | ₹5725.17 | +₹180.67 | +3.26% |
| R1 | ₹5634.83 | +₹90.33 | +1.63% |
| PIVOT | ₹5574.67 | 30.17 | 0.54% |
| CURRENT | ₹5544.50 | - | - |
| S1 | ₹5183.33 | -₹361.17 | -6.51% |
| S2 | ₹5333.83 | -₹210.67 | -3.80% |
| S3 | ₹5424.17 | -₹120.33 | -2.17% |
| S4 | ₹5484.33 | -₹60.17 | -1.09% |
is trading CPR, indicating
CPR is
Day's range: ~
Trading Inside opening range
| Company Name |
|---|
Abbott India Ltd |
Ajanta Pharma Ltd |
Aurobindo Pharma Ltd |
Cipla Ltd |
Dr Reddys Laboratories Ltd |
Glaxosmithkline Pharmaceuticals Ltd |
Glenmark Pharmaceuticals Ltd |
Ipca Laboratories Ltd |
Laurus Labs Ltd |
Lupin Ltd |
Mankind Pharma Ltd |
Sun Pharmaceutical Industries Ltd |
Torrent Pharmaceuticals Ltd |
Zydus Lifesciences Ltd |

Alkem Laboratories Limited is a multinational pharmaceutical company with a significant presence in India, the United States, and other international markets. Its core business revolves around the research, development, manufacturing, and sale of a diverse range of pharmaceutical and nutraceutical products. This broad portfolio allows them to cater to a wide spectrum of healthcare needs.
A major component of Alkem's business is the production and distribution of branded generic and generic drugs. These medications cover a wide range of therapeutic areas, including anti-infectives to combat infections, gastro-intestinal medications for digestive issues, pain relievers (analgesics), anti-diabetic treatments, drugs targeting the neuro/central nervous system, gynecological medications, respiratory treatments, dermatological products for skin conditions, and cardiac medications for heart health. This broad therapeutic reach underscores the company's commitment to comprehensive healthcare solutions.
Beyond branded and generic drugs, Alkem also manufactures and supplies active pharmaceutical ingredients (APIs). APIs are the fundamental building blocks of many medications, and their production represents a crucial aspect of the pharmaceutical supply chain. Alkem's involvement in API manufacturing strengthens its vertical integration within the industry and allows for greater control over the quality and supply of its finished products.
Furthermore, Alkem is venturing into the burgeoning biosimilars market. Biosimilars are similar to biologic drugs but are produced by different manufacturers, offering a potentially more affordable alternative. This expansion highlights Alkem's strategic focus on innovation and its commitment to providing cost-effective treatment options to patients.
Rounding out its offerings, Alkem produces and markets a range of nutraceuticals, which are products that provide health benefits beyond basic nutrition. This includes vitamins, minerals, and nutrients, as well as over-the-counter consumer products such as mouthwash, shampoos, pregnancy detection kits, and condoms. This diversification broadens their market reach and caters to a wider consumer base.
Established in 1973 and headquartered in Mumbai, India, Alkem Laboratories Limited has built a substantial presence in the global pharmaceutical landscape. Their multifaceted business strategy, encompassing a diverse range of products and therapeutic areas, positions them for continued growth and success in the competitive pharmaceutical industry.
Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel
Mumbai
MAHARASHTRA
IN
Tel: 912239829999
Website:https://www.alkemlabs.com/
Group: Pharmaceuticals, Biotechnology & Life Sciences
Sector: Health Care
Industry: Pharmaceuticals
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 17,432
IPO Date: 23/12/2015
Mr. Basudeo Singh
Executive Chairman of the Board
Dr. Vikas Gupta
Chief Executive Officer
Mr. Nitin Agrawal
President - Finance, Chief Financial Officer
Mr. Manish Narang
President - Legal, Chief Compliance Officer, Company Secretary
Mr. Sandeep Singh
Managing Director, Executive Director
Mrs. Madhurima Singh
Executive Director
Mr. Mritunjay Singh
Executive Director
Mr. Sarvesh Singh
Executive Director
Mr. Srinivas Singh
Executive Director
Mr. Narendra Aneja
Independent Director
Ms. Neela Bhattacherjee
Independent Director
Mr. Diwakar Gupta
Independent Director
Get answers to the most common questions about Alkem Laboratories Ltd stock price, fundamentals, financial metrics, and investment analysis